Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA approves new pain medicine
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
3d
on MSN
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
StudyFinds on MSN
1d
Journavx: What to know about new FDA-approved non-opioid pain medication
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Pauses tariffs on Canada, MX
'USAID to be shut down'
To block Trump nominees
Taiwanese actress dies at 48
Recall upgraded to Class I
Team name not changing
Workers put on leave
Winter storm warnings
Wrongful arrest settlement
Highway reopens after fires
Sweden rules out sabotage
North Korea slams Rubio
Garrett requests trade
Venezuelan protections end
Plans to cut South Africa aid
Staff must reveal probe role
Aimee Bock stands trial
Named acting head of CFPB
On trial over World Cup kiss
DC crash wreckage removal
Philly plane crash probe
New York shields prescribers
Martinez refinery fire
RU energy facilities attacked
Elliott wins Cook Out Clash
Set up joint company
Grammy Awards winners
Agent for ‘deep research’
Syria car bomb explosion
Teething sticks recalled
2023 train derailment suit
Feedback